Luke John Benvenuto, MD

Hilary Y. Robbins, MD earned her BA from Yale University and MD from Columbia University College of Physicians and Surgeons. She completed her training in Internal Medicine, followed by a fellowship in Pulmonary and Critical Care Medicine, at Columbia University Medical Center. Her fourth year of fellowship was supported by a grant from the Stony Wold-Herbert Fund. She is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. She joined the faculty in the Lung Transplant Program at Columbia as an assistant professor in 2010. Her professional society memberships include the American Thoracic Society, the American College of Chest Physicians, and the International Society of Heart and Lung Transplantation.

Claire Keating, MD is the Associate Director of the Gunnar Esiason Adult Cystic Fibrosis and Lung Program since 2009.

Dr. Quezada is an Assistant Professor of Clinical Medicine in the Division of Pulmonary, Allergy, and Critical Care Medicine. A native of Washington Heights, he received his Sc.B. with Honors in Biology from Brown University in Providence, Rhode Island, and his medical degree from Columbia University College of Physicians and Surgeons. He completed residency training in Internal Medicine, and Fellowship in Pulmonary and Critical Care Medicine, at Columbia University Medical Center, serving as Chief Fellow on his last year of fellowship training. He is board-certified in Internal Medicine and Pulmonary Disease by the American Board of Internal Medicine. Dr. Quezada specializes in providing excellent care of patients suffering from lung disease, including patients with asthma, COPD, and interstitial lung disease. He also has special interest in smoking cessation and interventional bronchoscopy. His research interests include smoking cessation, COPD and asthma, serving as a co-primary investigator in a multicenter NIH-sponsored clinical trial. He has also performed research looking into the relationship between sensitization and exposure to indoor allergens in asthma patients residing in inner city neighborhoods, and the development of tools to help identify patients with early COPD.